BILL ANALYSIS

HR4130

BEARISH

Small Business Relief Act

HR4130 (Small Business Relief Act) has been assessed with a bearish outlook for investors. The primary sectors impacted are Finance. View the full bill text on Congress.gov.

bearish

Market Sentiment

4/10

Impact Score

Sectors Impacted

Key Takeaways for Investors

HR4130 allows private companies to raise more institutional capital without triggering SEC registration, delaying IPOs.

Exchange operators $NDAQ and $ICE face reduced IPO listing revenue if this bill becomes law.

Bill is in early active stage (Union Calendar) but lacks Senate companion and bipartisan support, limiting near-term passage odds.

How HR4130 Affects the Market

The bill directly reduces IPO supply in the pipeline, a negative structural headwind for $NDAQ and $ICE. Over the trailing 30 days, both exchange stocks have rallied (NDAQ +7.98%, ICE +2.07%) despite this legislative overhang, indicating the market is discounting its passage. If the bill advances to a House floor vote with strong whip count, these stocks could underperform the broader market. $CME is largely unaffected since its revenues come from derivatives clearing and trading, not equity listings.

Bill Details

Metric	Value
Bill Number	HR4130
Market Sentiment	bearish
Event Date	February 25, 2026
Affected Sectors	Finance
Source	View on Congress.gov →

Summary

HR4130, the Small Business Relief Act, amends SEC registration thresholds to exclude qualified institutional buyers and institutional accredited investors from the shareholder count. This reduces the likelihood and urgency for private companies to go public, directly weighing on future listing revenue for exchange operators. The bill is actively progressing through the House with committee approval and a Union Calendar placement, but remains in early legislative stages.

Full AI Market Analysis

1) What happened: On 2025-06-25, Rep. Garbarino (R-NY) introduced HR4130 to amend Section 12(g)(1) of the Securities Exchange Act of 1934. The bill strips institutional investors from counting toward the SEC's mandatory registration threshold. It passed committee markup (28-24) on 2025-12-17 and was placed on the Union Calendar on 2026-02-25. The bill has only one cosponsor and no Senate companion, reducing its passage probability in the 119th Congress. 2) Money trail: This bill authorizes zero direct funding. Its mechanism is regulatory exemption, not spending. By allowing private companies (particularly high-growth startups and unicorns) to add institutional capital without triggering the 2,000 investor cap for SEC registration, it removes a key catalyst forcing companies to go public via IPO. This dries up supply of new listings for exchanges. 3) Winners and losers: Exchange operators $NDAQ (Nasdaq) and $ICE (NYSE) are structurally harmed because IPO listings are a significant revenue driver tied to listing fees and related trading volume. Private markets and institutional investors benefit, but there is no pure-play public company ticker representing that upside. $CME (CME Group) is negligible here as it focuses on derivatives, not equities listings. 4) Real market data: Over the trailing 30 days, $NDAQ is up +7.98% to $91.66, $ICE is up +2.07% to $160.54, and $CME is down -2.5% to $287.96. $NDAQ’s strong recent outperformance reflects broader tech and IPO optimism, not this bill, which is contrary to $NDAQ's interest. If the bill gains momentum, a correction in $NDAQ and $ICE relative to the market is plausible. 5) Timeline: The bill must pass the full House, then the Senate (no companion bill), then be signed by the President. With the 119th Congress running through January 2027 and an election year approaching, the window for passage is narrowing. The current Union Calendar status means it is eligible for floor vote but has not been scheduled.